BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2655750)

  • 1. Autoimmune chronic active hepatitis and primary biliary cirrhosis.
    Triger DR
    Baillieres Clin Gastroenterol; 1989 Jan; 3(1):21-38. PubMed ID: 2655750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report.
    Horsmans Y; Piret A; Brenard R; Rahier J; Geubel AP
    J Hepatol; 1994 Aug; 21(2):194-8. PubMed ID: 7989708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of autoimmune hepatitis in primary biliary cirrhosis.
    Gossard AA; Lindor KD
    Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
    Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
    Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
    Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis.
    Olsson R; Johansson C; Lindstedt G; Mellström D
    Scand J Gastroenterol; 1994 Aug; 29(8):753-6. PubMed ID: 7973437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of autoimmune hepatitis.
    Johnson PJ
    Gut; 1997 Jul; 41(1):3-4. PubMed ID: 9274462
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL
    Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy of autoimmune liver diseases].
    Rambusch EG; Manns MP
    Internist (Berl); 1997 Jun; 38(6):574-81. PubMed ID: 9265002
    [No Abstract]   [Full Text] [Related]  

  • 13. Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.
    Saeki R; Kaneko S; Terasaki S; Unoura M; Ogino H; Wakabayashi T; Kawara S; Nakanuma Y; Kobayashi K
    Hepatogastroenterology; 1993 Oct; 40(5):499-501. PubMed ID: 8270244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment of chronic liver disease.
    Jones EA; Bergasa NV
    Ann N Y Acad Sci; 1993 Nov; 696():319-27. PubMed ID: 8109838
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents.
    Mackay IR
    Med J Aust; 1987 Apr; 146(7):370-4. PubMed ID: 3561294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.
    Ozaslan E; Efe C; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Muratori L; Ustündag Y; Bresson-Hadni S; Thiéfin G; Schiano TD; Wahlin S; Muratori P
    Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary biliary cirrhosis].
    Chon CY; Park JY
    Korean J Hepatol; 2006 Sep; 12(3):364-72. PubMed ID: 16998288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectivity of immunosuppressive therapy on chronic aggressive (active) hepatitis and on chronic nonsuppurative destructive cholangitis (PBC). Morphometric investigations on the portal tracts of the liver.
    Volmer J
    Liver; 1982 Jun; 2(2):82-94. PubMed ID: 7176844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune liver diseases.
    Manns MP; Nakamura RM
    Clin Lab Med; 1988 Jun; 8(2):281-301. PubMed ID: 3284697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in the diagnosis and treatment of primary biliary liver cirrhosis].
    Salupere VP; Remmel' KhA; Uĭbo RM
    Ter Arkh; 1987; 59(2):112-4. PubMed ID: 3576463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.